Genomic Multiple Sclerosis Risk Variants Modulate the Expression of the


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2021
Historique:
received: 17 11 2021
accepted: 22 12 2021
entrez: 3 2 2022
pubmed: 4 2 2022
medline: 5 3 2022
Statut: epublish

Résumé

Intronic single-nucleotide polymorphisms (SNPs) in the

Identifiants

pubmed: 35111166
doi: 10.3389/fimmu.2021.816930
pmc: PMC8801523
doi:

Substances chimiques

ANKRD55 protein, human 0
Benzoates 0
Biomarkers 0
Carrier Proteins 0
IL6ST protein, human 0
Tetrahydronaphthalenes 0
Am 580 102121-60-8
Cytokine Receptor gp130 133483-10-0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

816930

Informations de copyright

Copyright © 2022 Mena, Alloza, Tulloch Navarro, Aldekoa, Díez García, Villanueva Etxebarria, Lindskog, Antigüedad, Boyero, Mendibe-Bilbao, Álvarez de Arcaya, Sánchez Menoyo, Midaglia, Villarrubia, Malhotra, Montalban, Villar, Comabella and Vandenbroeck.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Nat Genet. 2010 Jun;42(6):508-14
pubmed: 20453842
Ann Rheum Dis. 2015 Mar;74(3):e13
pubmed: 24532676
Immunity. 2013 Feb 21;38(2):336-48
pubmed: 23352235
J Immunol. 2007 Aug 15;179(4):2041-5
pubmed: 17675459
Cell. 2018 Nov 29;175(6):1701-1715.e16
pubmed: 30449622
Immunol Cell Biol. 2014 Jul;92(6):509-17
pubmed: 24638064
Nature. 2006 May 11;441(7090):235-8
pubmed: 16648838
Nature. 2012 Nov 1;491(7422):119-24
pubmed: 23128233
Nat Med. 2015 Sep;21(9):1018-27
pubmed: 26301688
Biochem Biophys Rep. 2021 Feb 01;25:100916
pubmed: 33553685
Eur J Biochem. 2001 Jan;268(1):160-7
pubmed: 11121117
Biochim Biophys Acta. 2011 May;1813(5):878-88
pubmed: 21296109
Vitam Horm. 2011;86:127-52
pubmed: 21419270
Genome Med. 2018 Dec 20;10(1):97
pubmed: 30572963
Nat Genet. 2013 Oct;45(10):1238-1243
pubmed: 24013639
Nat Genet. 2012 Dec;44(12):1336-40
pubmed: 23143596
Nat Genet. 2015 Sep;47(9):979-986
pubmed: 26192919
J Clin Invest. 2000 Jul;106(1):137-44
pubmed: 10880057
Blood. 1993 Aug 15;82(4):1120-6
pubmed: 8353278
Nat Genet. 2013 Nov;45(11):1353-60
pubmed: 24076602
Nat Med. 2007 Oct;13(10):1173-5
pubmed: 17828272
Front Immunol. 2015 Oct 19;6:528
pubmed: 26539195
Cytokine. 2014 Aug;68(2):86-93
pubmed: 24845797
Circ Res. 2020 Jan 31;126(3):330-346
pubmed: 31739742
Science. 2014 May 2;344(6183):519-23
pubmed: 24786080
Science. 2017 Apr 21;356(6335):
pubmed: 28428369
Nucleic Acids Res. 2017 Oct 13;45(18):10350-10368
pubmed: 28977640
Front Immunol. 2018 Dec 14;9:2934
pubmed: 30619294
J Med Genet. 2013 Mar;50(3):140-3
pubmed: 23315543
J Biol Chem. 2014 Aug 8;289(32):22140-50
pubmed: 24973212
Mucosal Immunol. 2014 Jan;7(1):101-13
pubmed: 23653115
Nature. 2014 Feb 20;506(7488):376-81
pubmed: 24390342
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Genes Immun. 2012 Apr;13(3):253-7
pubmed: 22130326
J Allergy Clin Immunol. 2020 May;145(5):1438-1451
pubmed: 31945409
Cell. 2016 Nov 17;167(5):1415-1429.e19
pubmed: 27863252
Nat Genet. 2017 Apr;49(4):600-605
pubmed: 28218759
Am J Hum Genet. 2011 Oct 7;89(4):496-506
pubmed: 21963258
JAMA Neurol. 2013 Mar 1;70(3):394-7
pubmed: 23358868
Front Immunol. 2019 Sep 18;10:2067
pubmed: 31620119
J Immunol. 2016 Feb 15;196(4):1558-67
pubmed: 26746191
Cell. 2020 Sep 3;182(5):1198-1213.e14
pubmed: 32888493
J Immunol. 2016 Jun 1;196(11):4553-65
pubmed: 27183579
Neurol Neuroimmunol Neuroinflamm. 2014 Sep 18;1(3):e33
pubmed: 25340085
Cell. 2020 Sep 3;182(5):1214-1231.e11
pubmed: 32888494
Science. 2019 Sep 27;365(6460):
pubmed: 31604244
Eur J Hum Genet. 2019 Nov;27(11):1745-1756
pubmed: 31296926
Drug Discov Today. 2021 Jul;26(7):1591-1601
pubmed: 33781948
Metabolism. 2014 May;63(5):647-53
pubmed: 24629561
JAMA Neurol. 2013 Mar 1;70(3):390-3
pubmed: 23599943
Brain. 2020 May 1;143(5):1414-1430
pubmed: 32282893
Nat Commun. 2021 Dec 6;12(1):7078
pubmed: 34873174
Mol Syst Biol. 2017 Jun 8;13(6):932
pubmed: 28596423
Cold Spring Harb Perspect Biol. 2018 Feb 1;10(2):
pubmed: 28620096
Immunology. 2018 May;154(1):3-20
pubmed: 29313948
Genes Immun. 2020 Feb;21(2):100-108
pubmed: 31932740
Semin Cell Dev Biol. 2015 May;41:9-22
pubmed: 25957517
Hum Mol Genet. 2019 Mar 1;28(5):858-874
pubmed: 30423114
Clin Immunol. 2018 Feb;187:15-25
pubmed: 28941836
Ann Rheum Dis. 2020 Oct 26;:
pubmed: 33106285

Auteurs

Jorge Mena (J)

Inflammation & Biomarkers Group, Biocruces-Bizkaia Health Research Institute, Barakaldo, Spain.

Iraide Alloza (I)

Inflammation & Biomarkers Group, Biocruces-Bizkaia Health Research Institute, Barakaldo, Spain.

Raquel Tulloch Navarro (R)

Inflammation & Biomarkers Group, Biocruces-Bizkaia Health Research Institute, Barakaldo, Spain.

Ane Aldekoa (A)

Inflammation & Biomarkers Group, Biocruces-Bizkaia Health Research Institute, Barakaldo, Spain.

Javier Díez García (J)

Microscopy Facility, Biocruces-Bizkaia Health Research Institute, Barakaldo, Spain.

Ane Villanueva Etxebarria (A)

Kronikgune Institute for Health Services Research, Barakaldo, Spain.
Health Service Research Network on Chronic Diseases Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC), Bizkaia, Spain.
Osakidetza-Basque Health Service, Research Unit, Galdakao University Hospital, Galdakao, Spain.

Cecilia Lindskog (C)

Department of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden.

Alfredo Antigüedad (A)

Department of Neurology, Cruces University Hospital, Osakidetza-Basque Health Service, Biocruces-Bizkaia Health Research Institute, Barakaldo, Spain.

Sabas Boyero (S)

Department of Neurology, Cruces University Hospital, Osakidetza-Basque Health Service, Biocruces-Bizkaia Health Research Institute, Barakaldo, Spain.

María Del Mar Mendibe-Bilbao (MDM)

Department of Neurology, Cruces University Hospital, Osakidetza-Basque Health Service, Biocruces-Bizkaia Health Research Institute, Barakaldo, Spain.

Amaya Álvarez de Arcaya (A)

Department of Neurology, Txagorritxu University Hospital, Osakidetza-Basque Health Service, Bioaraba Health Research Institute, Vitoria-Gasteiz, Spain.

José Luis Sánchez Menoyo (JL)

Department of Neurology, Galdakao-Usansolo University Hospital, Osakidetza-Basque Health Service, Biocruces-Bizkaia Health Research Institute, Galdakao, Spain.

Luciana Midaglia (L)

Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.

Noelia Villarrubia (N)

Department of Immunology, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Red Española de Esclerosis Múltiple (REEM), Madrid, Spain.

Sunny Malhotra (S)

Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.

Xavier Montalban (X)

Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.

Luisa María Villar (LM)

Department of Immunology, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Red Española de Esclerosis Múltiple (REEM), Madrid, Spain.

Manuel Comabella (M)

Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.

Koen Vandenbroeck (K)

Inflammation & Biomarkers Group, Biocruces-Bizkaia Health Research Institute, Barakaldo, Spain.
Department of Biochemistry and Molecular Biology, Universidad del País Vasco (UPV/EHU), Barrio Sarriena, Leioa, Spain.
Ikerbasque, Basque Foundation for Science, Bilbao, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH